Prospective Evaluation of Safety and Efficacy of BR Regimen in Previously Untreated CLL Patients

Recently CLL10 trial showed remarkable efficacy and tolerability of BR regimen in highly selected previously untreated CLL patients. The way BR performs in “real-world” settings has not been evaluated in prospective manner.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research